SMEInst-05-2016-2017
SMEInst-05-2016-2017
107 projects · €112,881,738 total EU contribution (project-level) · 108 participating organizations · 21 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€112,881,738
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (15)
- Spain (13)
- France (11)
- Italy (10)
- SE (10)
- IL (8)
- Germany (7)
- Netherlands (6)
- PT (6)
- DK (4)
- IE (3)
- PL (3)
- AT (2)
- IS (2)
- NO (2)
- BE (1)
- CZ (1)
- EE (1)
- HU (1)
- SI (1)
- TR (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- AENITIS TECHNOLOGIES2 projects · FR
- EBERS2 projects · ES
- THE ZEBRAFISH LAB2 projects · ES
- METAFORA BIOSYSTEMS2 projects · FR
- SYMCEL2 projects · SE
- 2CUREX A/S1 projects · DK
- 2CUREX GMBH1 projects · DE
- AMADIX1 projects · ES
- AEQUOR1 projects · UK
- AGLARIS1 projects · UK
- ALLTOX1 projects · IT
- ALTRATECH LIMITED1 projects · IE
Projects
Page 10 of 11
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
TheraPD: Smart and safer automated peritoneal dialysis by means of sterile connectivity, bio-sensors control systems and more biocompatible solutions for preventing rapid degradation of peritoneal mem TheraPD · 733108 | H2020 | €2,838,126 | €2,838,126 | Details |
A ground-breaking medical system selecting the most viable embryo for successful IVF pregnancy Fertissimo · 767556 | H2020 | €2,711,974 | €1,265,488 | Details |
Novel Arthritis Treatment with focus on natural Chitin Oligosaccharides Simecos · 761612 | H2020 | €50,000 | €71,429 | Details |
A rapid, low-cost, cervical cancer screening platform HoloCyt · 744918 | H2020 | €50,000 | €71,429 | Details |
The first compact and easy-to-use microreactor device for Body-On-Chip experiments. B-On-Chip · 762315 | H2020 | €50,000 | €71,429 | Details |
Arthroscopic Regenerative Medicine for Early-Stage Treatment of OA ARMOURY · 736269 | H2020 | €50,000 | €71,429 | Details |
A novel drug candidate for the treatment of Eosinophilic Esophagitis - an innovative solution for a significant unmet medical need theEoE · 745175 | H2020 | €50,000 | €71,429 | Details |
Acoustic Blood Cells Sorter ABC-S · 735942 | H2020 | €50,000 | €71,429 | Details |
Accelerating the commercialisation of a disruptive analytical technology which enables the biopharmaceutical industry to manufacture drugs faster, cheaper and with greater regulatory confidence BIOSIM · 778586 | H2020 | €2,029,325 | €2,029,325 | Details |
MAGIC (MAnufacturing of Gene delivery tools for Industrial and Clinical applications) LentiFactory · 762368 | H2020 | €50,000 | €71,429 | Details |